SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-13-023027
Filing Date
2013-03-21
Accepted
2013-03-21 17:28:15
Documents
2
Group Members
FRED A. MIDDLETONMIDDLETON, MCNEIL, MILLS & ASSOCIATES VI, LLCSANDERLING VENTURE PARTNERS VI CO-INVESTMENT FUND, L.P.SANDERLING VENTURES MANAGEMENT VISANDERLING VI BETEILIGUNGS GMBH & CO. KGSANDERLING VI LIMITED PARTNERSHIP

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a13-8201_1sc13da.htm SC 13D/A 243863
2 EX-99.1 a13-8201_1ex99d1.htm EX-99.1 7446
  Complete submission text file 0001104659-13-023027.txt   253273
Mailing Address 400 SOUTH E1 CAMINO REAL SUITE 1200 SAN MATEO CA 94402
Business Address 400 SOUTH E1 CAMINO REAL SUITE 1200 SAN MATEO CA 94402 650-401-1708
Sanderling Venture Partners VI LP (Filed by) CIK: 0001306717 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A

Mailing Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Subject) CIK: 0001396814 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86096 | Film No.: 13708505
SIC: 2834 Pharmaceutical Preparations